Andrew Singer

MVC Capital, Inc is private Equity fund invest in equity and debt investment capital to fund growth, acquisitions, and recapitalizations of small and middle-market companies located in the United States. company operates through the MVC and MVCFS segments. The MVC segment consists of MVC Cayman and MVC Turf. The MVCFS segment refers to its subsidiary which provides advisory, administrative, and other services to the company and its portfolio companies. It participates in senior and subordinated loans, common and preferred stock, and warrants or rights to acquire equity interests, or convertible securities requirements.

Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA.